Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 10,235 $ 33,469
Restricted cash and cash equivalents—current 2,964 4,978
Accounts receivable, net 1,241 2,188
Inventory 1,842 1,535
Prepaid expenses and other current assets, net 12,635 22,615
Total current assets 28,917 64,785
Restricted cash and cash equivalents—non current 560 598
Vehicle deposits 43,184 48,783
Vehicles, net 107,056 100,088
Goodwill 29,815 0
Other assets 12,905 11,402
Total assets 222,437 225,656
Current liabilities:    
Accounts payable 29,615 20,235
Accrued expenses 31,722 33,413
Deferred revenue 48,736 47,820
Notes payable—current 19,131 22,200
Other current liabilities 26,251 10,950
Total current liabilities 155,455 134,618
Notes payable—non current (including $59.0 million at September 30, 2023 and $30.1 million at December 31, 2022 of Convertible Senior Secured Notes measured at fair value) 83,160 56,205
Derivative liabilities 26 1,892
Other liabilities 8,958 7,831
Total liabilities 247,599 200,546
Commitments and contingencies (Note 12)
Stockholders’ (Deficit) Equity    
Class A common stock, $0.0001 par value, 40,000,000 shares authorized, and 14,183,016 and 10,507,830 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively, and Class X common stock, $0.0001 par value, 2,000,000 shares authorized, 1,381,398 shares issued and outstanding as of September 30, 2023 and December 31, 2022 32 30
Additional paid-in capital 1,596,449 1,572,576
Accumulated other comprehensive loss (8,328) (7,621)
Accumulated deficit (1,613,315) (1,539,875)
Total stockholders’ (deficit) equity (25,162) 25,110
Total liabilities and stockholders’ equity $ 222,437 $ 225,656